Report Categories
View AllRecent Articles
View All
Why Inflection IPEX is a smarter play than most realize Calm 20260507
Biomea BMEA Stock Index Trade Smart Money Flows 20260415
FBRX Forte Biosciences Inc reports wider than expected Q4 2025 loss with shares falling 352 following the earnings release
GH Guardant Health notches 329 Q4 2025 revenue growth yet wider than expected loss pushes stock down 089
AI Sector Operational Reputational and Regulatory Risk Analysis Following Targeted Executive Threats
The strategic moves Ecolab ECL is making now Breakdown Watch 20260511
SPAI Safe Pro posts wider than expected Q4 2025 loss yet shares rise 113 percent on investor optimism
NXP NXPI Stock Chart Pattern Insight NXP posts 04 EPS beat on solid auto chip demand
What Wheels Up UP is building for next year Q4 2025 EPS Tops Views
The strategic priorities reflected in CL NWGL results
Schwab US REIT ETF SCHH 2026 Performance Hinges on Interest Rate Trajectory and Top Holding Fundamentals
Cramer Argues Nvidias China AI Chip Sales Benefit US Interests Says Stock Can Succeed Either Way
Sunrise SUNS Crushes Q1 2026 Estimates EPS 032 Tops Views
Canadian Nat CNQ Reports Strong Q1 2026 Revenue NA EPS Beats
Cerebras IPO Debut Signals Strong Investor Appetite for AI Chip Stocks
US Economic Growth Rebounds in Q1 2026 as AI Infrastructure and Consumer Spending Drive Expansion
Genpact CEO Warns AI Will Reduce IT Workload and Lead to Job Cuts
Synopsys Expected to Report Lower Q2 Earnings as Analysts Adjust Forecasts
Disneys Star Wars The Mandalorian and Grogu Opens with FranchiseLow Thursday Previews of 12 Million
NASA Selects Blue Origin for Initial Uncrewed Lunar Mission in 20 Billion Moon Base Effort
Memorial Day Sales Reveal Consumer Caution Selective Spending Patterns Emerge
US Builds Ebola Treatment Center in Kenya for Exposed Americans Expert Raises Concerns
US Stock Markets Rally SP 500 Records Longest Winning Streak Since 2023 Dow Gains Over 2
Eagle Bancorp Montana Inc EBMT Q1 2026 Earnings Earnings Beat Driven by Solid Net Interest Margin
FLY Q1 2026 Earnings NarrowerthanExpected Loss Fails to Lift Shares
ORIC Q1 2026 Earnings NarrowerThanExpected Loss Pipeline Progress Keeps Focus on Key Milestones
BATRK Q1 2026 Earnings Loss Narrows Surpasses Analyst Expectations
EXPE Q1 2026 Earnings EPS Smashes Estimates by 384 Travel Demand Remains Resilient
Kairos Pharma Ltd KAPA Q1 2026 Earnings Widerthanexpected loss and muted stock response amid preclinical focus
Intuitive Surgical ISRG Drops Over 4 as Key Support Levels Tested
Plum Acquisition Corp IV Unit PLMKU Edges Higher Tests Key Resistance Level
Western Copper and Gold WRN Slips 208 as Support Levels Tested
Frontier Group Holdings ULCC Edges Lower as Traders Eye Key Support at 550
Tucows Inc TCX Edges Higher in Cautious Trading Remains Near Key Support
AstroNova Q1 2026 Earnings Narrowing Loss Amid Strategic Investments
GH Q1 2026 Earnings NarrowerthanExpected Loss Drives Stock Up 448
YB Q2 2025 Earnings EPS of 092 Drives Stock Rally Despite Limited Disclosure
NVCR Q1 2026 Earnings EPS Misses Estimates as Wider Loss Overshadows Modest Stock Advance
NCSM Q1 2026 Earnings Significant EPS Miss Amidst Operational Challenges
TransAlta Q1 2026 Earnings EPS Slightly Misses Estimates Amid Marginal Stock Gain
TWST Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher
NKTR Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Operational Challenges
SMR Q1 2026 Earnings EPS Miss Amid No Revenue Stock Rises
External Links
Plus500 Revenue Jumps 11 in Latest Quarter Company Reaffirms Annual Outlook
WPM Q1 2026 Earnings EPS Beats Expectations on Strong Precious Metals Performance
Ironwood Pharmaceuticals IRWD Edges Higher Amid Tight Trading Range
Bumble BMBL Hovers Near Support as Minor Gains Signal Cautious Sentiment
Geospace Technologies Slides 47 Testing Key Support as Oilfield Headwinds Persist
Anika Therapeutics ANIK Holds Steady Near Support as Slight Decline Persists
UMB Financial Preferred Shares UMBFO Hold Steady Near 2694 Amid Minimal Movement
Wheeler REIT Convertible Notes WHLRL Hold Steady at 8001 Amid Low Volatility
Oruka Therapeutics ORKA Holds Steady Near Resistance as Traders Eye Key Levels
Hoth Therapeutics Holds Steady at 136 Key Levels in Focus as Volume Normalizes